Literature DB >> 17217287

Przewalskin B, a novel diterpenoid with an unprecedented skeleton from Salvia przewalskii maxim.

Gang Xu1, Ai-Jun Hou, Yong-Tang Zheng, Yu Zhao, Xiao-Li Li, Li-Yan Peng, Qin-Shi Zhao.   

Abstract

Przewalskin B (1), a novel diterpenoid possessing a unique skeleton, was isolated from a Chinese medicinal plant Salvia przewalskii. Its structure and relative stereochemistry were elucidated by extensive NMR analysis and a single-crystal X-ray study. A possible biosynthetic pathway for 1 was proposed. Compound 1 exhibited modest anti-HIV-1 activity with EC50 = 30 microg/mL. [structure: see text].

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17217287     DOI: 10.1021/ol062748d

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

1.  Divergent stereocontrol of acid catalyzed intramolecular aldol reactions of 2,3,7-triketoesters: synthesis of highly functionalized cyclopentanones.

Authors:  Phong Truong; Charles S Shanahan; Michael P Doyle
Journal:  Org Lett       Date:  2012-06-28       Impact factor: 6.005

2.  Enantioselective Nazarov Cyclization Catalyzed by a Cinchona Alkaloid Derivative.

Authors:  Yu-Wen Huang; Alison J Frontier
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

3.  Enyne diketones as substrate in asymmetric Nazarov cyclization for construction of chiral allene cyclopentenones.

Authors:  Shengbiao Tang; Peng Zhang; Ying Shao; Jiangtao Sun
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

4.  Regioisomers Salviprolin A and B, Unprecedented Rosmarinic Acid Conjugated Dinorditerpenoids from Salvia przewalskii Maxim.

Authors:  Xiangdong Su; Yichuang Wu; Meifang Wu; Jielang Lu; Shujie Jia; Xin He; Shuna Liu; Yuyang Zhou; Hui Xing; Yongbo Xue
Journal:  Molecules       Date:  2021-11-18       Impact factor: 4.411

5.  Molecular Mechanism of Salvia miltiorrhiza Bunge in Treating Cerebral Infarction.

Authors:  Xietao Ye; Jiali Liu; Xinyao Yuan; Songhong Yang; Yi Huang; Yan Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

6.  Synthesis and Cytotoxicities of Royleanone Derivatives.

Authors:  Cheng-Ji Li; Fan Xia; Rong Wu; Hong-Sheng Tan; Hong-Xi Xu; Gang Xu; Hong-Bo Qin
Journal:  Nat Prod Bioprospect       Date:  2018-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.